Novavax, Moderna, Pfizer and its partner BioNTech are slated to roll out new shots designed to target the omicron subvariant XBB.1.5 this fall.
Source:https://www.cnbc.com/2023/08/21/covid-vaccine-stocks-jump-as-new-variants-emerge.html
Source:https://www.cnbc.com/2023/08/21/covid-vaccine-stocks-jump-as-new-variants-emerge.html
© 2010-2022 Billy Tang
Supported By Growth SpeedUp Company
© 2010-2022 Billy Tang
Supported By Growth SpeedUp Company